Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

Get Premium

Register

Sign In

EUR/USD

1.2217

-0.0019

-0.16%

GBP/USD

1.3852

-0.0040

-0.29%

USD/JPY

110.83

-0.1945

-0.18%

USD/CHF

0.9640

0.0051

0.53%

EUR/GBP

0.8820

0.0012

0.14%

USD/CAD

1.2498

0.0088

0.71%

NZD/USD

0.7275

-0.0019

-0.27%

EUR/JPY

135.41

-0.4460

-0.33%

EUR/CHF

1.1779

0.0046

0.39%

Abeona Therapeutics

NASDAQ: ABEOHealthcare / Biotechnology / USA
14.60+0.05+0.34%Vol 410 8291Y Perf 192.00%
Jan 19th, 2018 16:00
BID14.55 ASK14.60
Open14.65 Previous Close14.55
Pre-Market14.80 After-Trading14.60
 0.25 1.72%  - -%
Target Price
29.71 
Analyst Rating
Strong Buy 1.14
Potencial %
103.49 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)683 
Earnings Rating
Price Range Ratio 52wk %
55.34 
Earnings Date

Today's Price Range

14.2414.93

 

52wk Range

4.5022.75

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-4.70%
3 Months
-17.75%
6 Months
48.22%
1 Year
192.00%
3 Years
349.23%
5 Years
-14.12%
Last Quotes
Name / TickerPriceChg.Chg.%
ABEO14.600.05000.34
AAPL178.46-0.8000-0.45
GOOG1 137.517.72000.68
MSFT90.00-0.1000-0.11
XOM87.15-0.2800-0.32
WFC64.220.27000.42
JNJ147.360.44000.30
FB181.291.49000.83
GE16.26-0.5100-3.04
JPM113.01-0.2500-0.22
...

TickerPriceChg.%52 Week High
MAT16.145.9831.60
HBI23.205.4525.73
NKE67.214.8467.24
KSS67.544.1567.55
UA12.853.8826.25
PM108.923.66123.55
LOW104.953.54105.60
WYN126.993.47127.96
LB50.693.4163.10
PBCT20.083.3520.12
FL50.213.3377.86
AMG212.003.25213.86
HCA93.013.2293.32
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 21.50
Current Ratio 22.10
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -2 873.60
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-2 945.60
EBITDA Margin-2 849.50
Pre-tax Profit Margin-1 798.90
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 8.17
PS Ratios 1 191.94
Price to Cash Flow 30.10
Price to Free Cash Flow -41.30
Cash Flow Per Share -0.53
Price to Tangible Book13.76
Book Value per Share1.92
Enterprise Value (in ths.)677 850
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-94.60
ROE last 12 Months -33.74
Return on Assets (5Y Avg) -18.17
ROA last 12 Months -30.52
Return on Capital (5Y Avg) -
ROC last 12 Months -32.50
Return on invested Capital Q -5.99
Return on invested Capital Y-28.63
Assets Turnover0.00
Receivables Turnover1.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)622
Revenue per Share 0.01
Revenue Growth 3 Years -9.59
Revenue Growth 5 Years -29.77
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q03 2017-0.18-0.1327.78
Q02 2017-0.13-0.21-61.54
Q01 2017-0.13-0.130.00
Q04 2016-0.13-0.19-46.15
Q03 2016-0.17-0.0852.94
Q02 2016-0.14-0.20-42.86
Q01 2016-0.11-0.17-54.55
Q03 2015-0.11-0.19-72.73
Earnings Per EndEstimateRevision %Trend
12/2017 QR-0.1313.33Positive
12/2017 FY-0.609.09Positive
3/2018 QR-0.1620.00Positive
12/2018 FY-0.689.33Positive
Next Report Date13th Nov 2017
Estimated EPS Next Report-0.18
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume410 829
Shares Outstanding (in ths.)46 780
Trades Count2 060
Dollar Volume5 549 275
Avg. Volume541 302
Avg. Weekly Volume488 846
Avg. Monthly Volume543 686
Avg. Quarterly Volume791 029

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

52%48%

Bearish Bullish

73%27%

Bearish Bullish

68%32%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (85.71 %)
6 (85.71 %)
5 (83.33 %)
Moderate Buy
1 (14.29 %)
1 (14.29 %)
1 (16.67 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.14
Strong Buy
1.14
Strong Buy
1.17

There are no comments yet.

News

x